Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
317.43
308.50
291.61
264.08
249.66
229.86
209.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
317.43
308.50
291.61
264.08
249.66
229.86
209.50
Raw Material Cost
118.17
109.85
92.36
95.29
74.80
62.60
71.33
Purchase of Finished goods
37.55
35.19
35.40
38.00
44.42
40.03
26.89
(Increase) / Decrease In Stocks
-9.59
-2.50
9.91
-4.31
-1.90
8.52
0.66
Employee Cost
62.11
56.86
51.41
45.98
32.81
26.54
30.66
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
59.95
57.99
50.66
43.31
44.93
40.24
36.23
Total Expenditure (Excl Depreciation)
268.19
257.38
239.74
218.27
195.07
177.93
165.77
Operating Profit (PBDIT) excl Other Income
49.24
51.12
51.87
45.81
54.59
51.93
43.73
Other Income
22.50
20.39
16.39
12.22
5.47
2.40
3.82
Operating Profit (PBDIT)
71.74
71.51
68.26
58.03
60.06
54.33
47.55
Interest
0.44
0.79
0.81
0.55
0.58
0.60
1.23
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
71.30
70.72
67.45
57.48
59.48
53.73
46.32
Depreciation
7.10
6.45
5.13
4.49
3.91
3.77
3.62
Profit Before Tax
64.20
64.26
62.32
52.99
55.57
49.96
42.70
Tax
16.54
14.26
15.65
14.26
14.84
13.78
11.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
47.66
50.00
46.67
38.72
40.73
36.18
31.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
47.66
50.00
46.67
38.72
40.73
36.18
31.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-0.01
-0.01
-0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
47.66
50.00
46.67
38.72
40.72
36.17
31.58
Equity Capital
20.03
20.03
20.03
20.03
20.00
20.00
20.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
393.02
0.00
0.00
Earnings per share (EPS)
23.79
24.96
23.3
19.33
20.36
18.09
15.79
Diluted Earnings per share
23.79
24.96
23.3
19.33
20.36
18.08
15.79
Operating Profit Margin (Excl OI)
15.51%
16.57%
17.79%
17.35%
21.87%
22.59%
20.87%
Gross Profit Margin
22.46%
22.92%
23.13%
21.77%
23.82%
23.38%
22.11%
PAT Margin
15.01%
16.21%
16.0%
14.66%
16.31%
15.74%
15.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 2.89% vs 5.79% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is -4.68% vs 7.14% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is -3.68% vs -1.45% in Sep 2024
Interest
Growth in half year ended Sep 2025 is -44.30% vs -2.47% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Lincoln Pharma. With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
317.43
329.93
-12.50
-3.79%
Other Operating Income
0.00
0.00
0.00
Total Operating income
317.43
329.93
-12.50
-3.79%
Raw Material Cost
118.17
177.84
-59.67
-33.55%
Purchase of Finished goods
37.55
4.13
33.42
809.20%
(Increase) / Decrease In Stocks
-9.59
-0.51
-9.08
-1,780.39%
Employee Cost
62.11
43.28
18.83
43.51%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
58.85
-58.85
-100.00%
Other Expenses
59.95
0.00
59.95
Total Expenditure (Excl Depreciation)
268.19
283.59
-15.40
-5.43%
Operating Profit (PBDIT) excl Other Income
49.24
46.34
2.90
6.26%
Other Income
22.50
5.12
17.38
339.45%
Operating Profit (PBDIT)
71.74
51.46
20.28
39.41%
Interest
0.44
0.02
0.42
2,100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
71.30
51.44
19.86
38.61%
Depreciation
7.10
12.35
-5.25
-42.51%
Profit Before Tax
64.20
39.09
25.11
64.24%
Tax
16.54
9.36
7.18
76.71%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
47.66
29.73
17.93
60.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
47.66
29.73
17.93
60.31%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
47.66
29.73
17.93
60.31%
Equity Capital
20.03
13.37
6.66
49.81%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
23.79
22.24
1.55
6.97%
Diluted Earnings per share
23.79
22.24
1.55
6.97%
Operating Profit Margin (Excl OI)
15.51%
14.05%
0.00
1.46%
Gross Profit Margin
22.46%
15.59%
0.00
6.87%
PAT Margin
15.01%
9.01%
0.00
6.00%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 317.43 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 2.89% vs 5.79% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 47.66 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -4.68% vs 7.14% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.24 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -3.68% vs -1.45% in Sep 2024
Half Yearly - Interest
Interest 0.44 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -44.30% vs -2.47% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.51%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
